| Year |
Citation |
Score |
| 2019 |
Yu X, Dobrikov M, Keir ST, Gromeier M, Pastan IH, Reisfeld R, Bigner DD, Chandramohan V. Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. Plos One. 14: e0210608. PMID 30625226 DOI: 10.1371/Journal.Pone.0210608 |
0.383 |
|
| 2017 |
Erbe AK, Wang W, Carmichael L, Kim K, Mendonca EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, et al. Neuroblastoma Patients' KIR and KIR-ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28972044 DOI: 10.1158/1078-0432.Ccr-17-1767 |
0.315 |
|
| 2014 |
Chen S, Li X, Lu D, Xu Y, Mou W, Wang L, Chen Y, Liu Y, Li X, Li LY, Liu L, Stupack D, Reisfeld RA, Xiang R, Li N. SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells. Carcinogenesis. 35: 613-23. PMID 24233838 DOI: 10.1093/Carcin/Bgt371 |
0.333 |
|
| 2013 |
Gomez-Cabrero A, Wrasidlo W, Reisfeld RA. IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model. Plos One. 8: e73607. PMID 24014113 DOI: 10.1371/Journal.Pone.0073607 |
0.327 |
|
| 2013 |
Yang RK, Kalogriopoulos NA, Rakhmilevich AL, Ranheim EA, Seo S, Kim K, Alderson KL, Gan J, Reisfeld RA, Gillies SD, Hank JA, Sondel PM. Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Cancer Immunology, Immunotherapy : Cii. 62: 1303-13. PMID 23661160 DOI: 10.1007/S00262-013-1430-X |
0.354 |
|
| 2013 |
Reisfeld RA. The tumor microenvironment: a target for combination therapy of breast cancer. Critical Reviews in Oncogenesis. 18: 115-33. PMID 23237555 DOI: 10.1615/Critrevoncog.V18.I1-2.70 |
0.366 |
|
| 2013 |
Yang J, Liao D, Chen C, Liu Y, Chuang TH, Xiang R, Markowitz D, Reisfeld RA, Luo Y. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells (Dayton, Ohio). 31: 248-58. PMID 23169551 DOI: 10.1002/Stem.1281 |
0.325 |
|
| 2013 |
Liu Z, Xiong M, Liao D, Lv D, Reisfeld RA, Wrasidlo W, Chen S, Stupack DG, Sun P, Tan X, Xiang R. Abstract 5614: Legumain protease substrate modified TAT-liposome cargo: an efficient tool for targeting malignant diseases. Cancer Research. 73: 5614-5614. DOI: 10.1158/1538-7445.Am2013-5614 |
0.359 |
|
| 2012 |
Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D, Li N. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. Plos One. 7: e36326. PMID 22615765 DOI: 10.1371/Journal.Pone.0036326 |
0.309 |
|
| 2012 |
Lu D, Chen S, Tan X, Li N, Liu C, Li Z, Liu Z, Stupack DG, Reisfeld RA, Xiang R. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. Cancer Research. 72: 3451-6. PMID 22586064 DOI: 10.1158/0008-5472.Can-11-2536 |
0.342 |
|
| 2012 |
Gomez-Cabrero A, Liao D, Nguyen G, Reisfeld R. Abstract 3366: An inhibitor of the NF-kappaB pathway targets cancer stem cells and prevents tumor recurrence Cancer Research. 72: 3366-3366. DOI: 10.1158/1538-7445.Am2012-3366 |
0.354 |
|
| 2012 |
Yang RK, Kalogriopoulos NA, Rakhmilevich AL, Ranheim EA, Seo S, Kim K, Alderson KL, Gan J, Reisfeld RA, Gillies SD, Hank JA, Sondel PM. Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention Cancer Research. 72: 1538-1538. DOI: 10.1158/1538-7445.Am2012-1538 |
0.338 |
|
| 2011 |
Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. International Immunopharmacology. 11: 1877-86. PMID 21854876 DOI: 10.1016/J.Intimp.2011.07.019 |
0.433 |
|
| 2011 |
Liao D, Liu Z, Wrasidlo WJ, Luo Y, Nguyen G, Chen T, Xiang R, Reisfeld RA. Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model. Cancer Research. 71: 5688-96. PMID 21784871 DOI: 10.1158/0008-5472.Can-11-1264 |
0.406 |
|
| 2011 |
Liao D, Liu Z, Wrasidlo W, Chen T, Luo Y, Xiang R, Reisfeld RA. Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine : Nanotechnology, Biology, and Medicine. 7: 665-73. PMID 21419870 DOI: 10.1016/J.Nano.2011.03.001 |
0.322 |
|
| 2011 |
Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunology, Immunotherapy : Cii. 60: 731-8. PMID 21340652 DOI: 10.1007/S00262-011-0971-0 |
0.328 |
|
| 2011 |
Buhtoiarov IN, Neal ZC, Gan J, Buhtoiarova TN, Patankar MS, Gubbels JA, Hank JA, Yamane B, Rakhmilevich AL, Reisfeld RA, Gillies SD, Sondel PM. Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. Journal of Leukocyte Biology. 89: 625-38. PMID 21248148 DOI: 10.1189/Jlb.0710422 |
0.38 |
|
| 2011 |
Lu D, Chen S, Liao D, Liu Z, Xiang R, Reisfeld R. Abstract 3342: Overexpression of transcription factor Fra-1 drives murine 4TO7 breast cancer stem cells out of dormancy and render them sensitive to chemotherapy Cancer Research. 71: 3342-3342. DOI: 10.1158/1538-7445.Am2011-3342 |
0.33 |
|
| 2010 |
Delgado DC, Hank JA, Kolesar J, Lorentzen D, Gan J, Seo S, Kim K, Shusterman S, Gillies SD, Reisfeld RA, Yang R, Gadbaw B, DeSantes KB, London WB, Seeger RC, et al. Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Research. 70: 9554-61. PMID 20935224 DOI: 10.1158/0008-5472.Can-10-2211 |
0.328 |
|
| 2010 |
Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, ... Reisfeld RA, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. The New England Journal of Medicine. 363: 1324-34. PMID 20879881 DOI: 10.1056/Nejmoa0911123 |
0.323 |
|
| 2010 |
Luo YP, Zhou H, Krueger J, Kaplan C, Liao D, Markowitz D, Liu C, Chen T, Chuang TH, Xiang R, Reisfeld RA. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene. 29: 662-73. PMID 19966854 DOI: 10.1038/Onc.2009.308 |
0.344 |
|
| 2010 |
Xiang R, Liao D, Chen MT, Chuang T, Reisfeld RA, Luo YP. Abstract 4232: Tumor-associated macrophages are responsible for EGF-R triggered upregulation of the Sox-2 signaling pathway in CSCs, which enhance tumorigenicity and tumor metastasis Cancer Research. 70: 4232-4232. DOI: 10.1158/1538-7445.Am10-4232 |
0.352 |
|
| 2010 |
Luo YP, Liao D, Chuang T, Xiang R, Reisfeld RA. Abstract 1914: Cross-talk between breast cancer cells and tumor-associated macrophages leads to tumor cell invasion, angiogenesis and metastasis Cancer Research. 70: 1914-1914. DOI: 10.1158/1538-7445.Am10-1914 |
0.346 |
|
| 2009 |
Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model Plos One. 4. PMID 19956757 DOI: 10.1371/Journal.Pone.0007965 |
0.387 |
|
| 2008 |
Johnson EE, Lum HD, Rakhmilevich AL, Schmidt BE, Furlong M, Buhtoiarov IN, Hank JA, Raubitschek A, Colcher D, Reisfeld RA, Gillies SD, Sondel PM. Intratumoral immunocytokine treatment results in enhanced antitumor effects. Cancer Immunology, Immunotherapy : Cii. 57: 1891-902. PMID 18438664 DOI: 10.1007/S00262-008-0519-0 |
0.339 |
|
| 2008 |
Xiang R, Luo Y, Niethammer AG, Reisfeld RA. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis Immunological Reviews. 222: 117-128. PMID 18363997 DOI: 10.1111/J.1600-065X.2008.00613.X |
0.381 |
|
| 2008 |
Lewēn S, Zhou H, Hu HD, Cheng T, Markowitz D, Reisfeld RA, Xiang R, Luo Y. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunology, Immunotherapy : Cii. 57: 507-15. PMID 17786443 DOI: 10.1007/S00262-007-0389-X |
0.376 |
|
| 2008 |
Schrama D, Voigt H, Eggert AO, Xiang R, Zhou H, Schumacher TN, Andersen MH, thor Straten P, Reisfeld RA, Becker JC. Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunology, Immunotherapy : Cii. 57: 85-95. PMID 17605009 DOI: 10.1007/S00262-007-0352-X |
0.344 |
|
| 2007 |
Zeng Y, Huebener N, Fest S, Weixler S, Schroeder U, Gaedicke G, Xiang R, Schramm A, Eggert A, Reisfeld RA, Lode HN. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Cancer Research. 67: 2331-8. PMID 17332365 DOI: 10.1158/0008-5472.Can-06-3041 |
0.394 |
|
| 2007 |
Luo Y, Markowitz D, Xiang R, Zhou H, Reisfeld RA. FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice. Vaccine. 25: 1409-15. PMID 17113202 DOI: 10.1016/J.Vaccine.2006.10.043 |
0.366 |
|
| 2007 |
Reisfeld RA. Memory T cells: death by acquisition Blood. 109: 2269-2270. DOI: 10.1182/Blood-2007-01-064600 |
0.329 |
|
| 2006 |
Kaplan CD, Krüger JA, Zhou H, Luo Y, Xiang R, Reisfeld RA. A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine. 24: 6994-7002. PMID 17050049 DOI: 10.1016/J.Vaccine.2006.04.071 |
0.357 |
|
| 2006 |
Kim B, Suvas S, Sarangi PP, Lee S, Reisfeld RA, Rouse BT. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. Journal of Immunology (Baltimore, Md. : 1950). 177: 4122-31. PMID 16951377 DOI: 10.4049/Jimmunol.177.6.4122 |
0.313 |
|
| 2006 |
Kruger JA, Kaplan CD, Luo Y, Zhou H, Markowitz D, Xiang R, Reisfeld RA. Characterization of stem cell-like cancer cells in immune-competent mice. Blood. 108: 3906-12. PMID 16912222 DOI: 10.1182/Blood-2006-05-024687 |
0.366 |
|
| 2006 |
Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R. Targeting tumor-associated macrophages as a novel strategy against breast cancer. The Journal of Clinical Investigation. 116: 2132-2141. PMID 16862213 DOI: 10.1172/Jci27648 |
0.365 |
|
| 2006 |
Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. The Journal of Clinical Investigation. 116: 1955-62. PMID 16794736 DOI: 10.1172/Jci26532 |
0.383 |
|
| 2006 |
Lee SH, Mizutani N, Mizutani M, Luo Y, Zhou H, Kaplan C, Kim SW, Xiang R, Reisfeld RA. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunology, Immunotherapy : Cii. 55: 1565-74. PMID 16565828 DOI: 10.1007/S00262-006-0155-5 |
0.375 |
|
| 2006 |
Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM, et al. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1750-9. PMID 16551859 DOI: 10.1158/1078-0432.Ccr-05-2000 |
0.309 |
|
| 2006 |
Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 5: 147-59. PMID 16424916 DOI: 10.1038/Nrd1957 |
0.336 |
|
| 2006 |
Wu W, Luo Y, Sun C, Liu Y, Kuo P, Varga J, Xiang R, Reisfeld R, Janda KD, Edgington TS, Liu C. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms. Cancer Research. 66: 970-80. PMID 16424032 DOI: 10.1158/0008-5472.Can-05-2591 |
0.364 |
|
| 2006 |
Zhou H, Luo Y, Kaplan CD, Krüger JA, Lee SH, Xiang R, Reisfeld RA. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor. Blood. 107: 3251-7. PMID 16368879 DOI: 10.1182/Blood-2005-10-4231 |
0.344 |
|
| 2006 |
Schrama D, Voigt H, Eggert AO, Xiang R, Reisfeld RA, Becker JC. Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells. Cancer Immunology, Immunotherapy : Cii. 55: 861-6. PMID 16158274 DOI: 10.1007/S00262-005-0076-8 |
0.393 |
|
| 2005 |
Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Graham P, Thompson JF, Reisfeld RA, Kearsley J. Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biology & Therapy. 4: 1318-24. PMID 16322682 DOI: 10.4161/Cbt.4.12.2251 |
0.348 |
|
| 2005 |
Zhou H, Luo Y, Lo JF, Kaplan CD, Mizutani M, Mizutani N, Lee JD, Primus FJ, Becker JC, Xiang R, Reisfeld RA. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proceedings of the National Academy of Sciences of the United States of America. 102: 10846-51. PMID 16040807 DOI: 10.1073/Pnas.0502208102 |
0.377 |
|
| 2005 |
Loeffler M, Krüger JA, Reisfeld RA. Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Research. 65: 5027-30. PMID 15958544 DOI: 10.1158/0008-5472.Can-05-0646 |
0.382 |
|
| 2005 |
Zhou H, Luo Y, Mizutani M, Mizutani N, Reisfeld RA, Xiang R. T cell-mediated suppression of angiogenesis results in tumor protective immunity. Blood. 106: 2026-32. PMID 15920006 DOI: 10.1182/Blood-2005-03-0969 |
0.382 |
|
| 2005 |
Lo JF, Zhou H, Fearns C, Reisfeld RA, Yang Y, Lee JD. Tid1 is required for T cell transition from double-negative 3 to double-positive stages. Journal of Immunology (Baltimore, Md. : 1950). 174: 6105-12. PMID 15879105 DOI: 10.4049/Jimmunol.174.10.6105 |
0.336 |
|
| 2005 |
Luo Y, Zhou H, Mizutani M, Mizutani N, Liu C, Xiang R, Reisfeld RA. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence. Cancer Research. 65: 3419-27. PMID 15833877 DOI: 10.1158/0008-5472.Can-04-3120 |
0.414 |
|
| 2005 |
Niethammer AG, Wodrich H, Loeffler M, Lode HN, Emmerich K, Abdollahi A, Krempien R, Debus J, Huber PE, Reisfeld RA. Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 158-9. PMID 15498893 DOI: 10.1096/Fj.04-2355Fje |
0.408 |
|
| 2004 |
Mizutani N, Luo Y, Mizutani M, Reisfeld RA, Xiang R. DNA vaccines suppress angiogenesis and protect against growth of breast cancer metastases. Breast Disease. 20: 81-91. PMID 15687710 DOI: 10.3233/Bd-2004-20110 |
0.344 |
|
| 2004 |
Neal ZC, Yang JC, Rakhmilevich AL, Buhtoiarov IN, Lum HE, Imboden M, Hank JA, Lode HN, Reisfeld RA, Gillies SD, Sondel PM. Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4839-47. PMID 15269160 DOI: 10.1158/1078-0432.Ccr-03-0799 |
0.336 |
|
| 2004 |
Reisfeld RA, Niethammer AG, Luo Y, Xiang R. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis Immunological Reviews. 199: 181-190. PMID 15233734 DOI: 10.1111/J.0105-2896.2004.00137.X |
0.372 |
|
| 2004 |
Zhou H, Luo Y, Mizutani M, Mizutani N, Becker JC, Primus FJ, Xiang R, Reisfeld RA. A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines. The Journal of Clinical Investigation. 113: 1792-8. PMID 15199414 DOI: 10.1172/Jci21107 |
0.344 |
|
| 2004 |
Reisfeld RA, Niethammer AG, Luo Y, Xiang R. DNA vaccines designed to inhibit tumor growth by suppression of angiogenesis International Archives of Allergy and Immunology. 133: 295-304. PMID 14988601 DOI: 10.1159/000077009 |
0.377 |
|
| 2004 |
Neal ZC, Imboden M, Rakhmilevich AL, Kim KM, Hank JA, Surfus J, Dixon JR, Lode HN, Reisfeld RA, Gillies SD, Sondel PM. NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunology, Immunotherapy : Cii. 53: 41-52. PMID 14504825 DOI: 10.1007/S00262-003-0435-2 |
0.43 |
|
| 2004 |
Niethammer AG, Wodrich H, Loeffler M, Lode H, Krempien R, Huber PE, Debus J, Reisfeld RA. MDR-1 Recognition by Cytotoxic T Cells. Blood. 104: 1346-1346. DOI: 10.1182/Blood.V104.11.1346.1346 |
0.416 |
|
| 2004 |
Yang JC, Neal Z, Rakhmilevich A, Buhtoiarov I, Lum H, Imboden M, Hank J, Lode H, Reisfeld R, Gillies S, Sondel P. Addition of systemic IL2 increases effectiveness of hu14.18-IL2 immunocytokine therapy against NXS2 murine neuroblastoma Journal of the American College of Surgeons. 199: 54-55. DOI: 10.1016/J.Jamcollsurg.2004.05.112 |
0.353 |
|
| 2003 |
Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld RA, Xiang R. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proceedings of the National Academy of Sciences of the United States of America. 100: 8850-5. PMID 12857959 DOI: 10.1073/Pnas.1033132100 |
0.398 |
|
| 2003 |
Luo Y, O'Hagan D, Zhou H, Singh M, Ulmer J, Reisfeld RA, James Primus F, Xiang R. Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice. Vaccine. 21: 1938-47. PMID 12706680 DOI: 10.1016/S0264-410X(02)00821-6 |
0.406 |
|
| 2003 |
Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood. 101: 649-54. PMID 12393580 DOI: 10.1182/Blood-2002-02-0391 |
0.381 |
|
| 2002 |
Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceir BP, Reisfeld RA. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth Nature Medicine. 8: 1369-1375. PMID 12415261 DOI: 10.1038/Nm1202-794 |
0.381 |
|
| 2002 |
Wrasidlo W, Gaedicke G, Guy RK, Renaud J, Pitsinos E, Nicolaou KC, Reisfeld RA, Lode HN. A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models. Bioconjugate Chemistry. 13: 1093-9. PMID 12236791 DOI: 10.1021/Bc0200226 |
0.313 |
|
| 2002 |
Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN. T cell homeostatic proliferation elicits effective antitumor autoimmunity. The Journal of Clinical Investigation. 110: 185-92. PMID 12122110 DOI: 10.1172/Jci15175 |
0.393 |
|
| 2002 |
Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA. Tumor regression by targeted gene delivery to the neovasculature Science. 296: 2404-2407. PMID 12089446 DOI: 10.1126/Science.1070200 |
0.326 |
|
| 2002 |
Schrama D, Straten Pt, Bröcker EB, Reisfeld RA, Becker JC. Cytokine fusion protein treatment. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 160: 185-94. PMID 12079213 DOI: 10.1007/978-3-642-59410-6_22 |
0.383 |
|
| 2001 |
Ruehlmann JM, Xiang R, Niethammer AG, Ba Y, Pertl U, Dolman CS, Gillies SD, Reisfeld RA. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Research. 61: 8498-503. PMID 11731434 |
0.303 |
|
| 2001 |
Niethammer AG, Primus FJ, Xiang R, Dolman CS, Ruehlmann JM, Ba Y, Gillies SD, Reisfeld RA. An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice. Vaccine. 20: 421-9. PMID 11672905 DOI: 10.1016/S0264-410X(01)00362-0 |
0.397 |
|
| 2001 |
Xiang R, Primus FJ, Ruehlmann JM, Niethammer AG, Silletti S, Lode HN, Dolman CS, Gillies SD, Reisfeld RA. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 4560-5. PMID 11591784 DOI: 10.4049/Jimmunol.167.8.4560 |
0.362 |
|
| 2001 |
Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma. Cancer Research. 61: 6178-84. PMID 11507070 |
0.305 |
|
| 2001 |
Shabat D, Lode HN, Pertl U, Reisfeld RA, Rader C, Lerner RA, Barbas CF. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 98: 7528-33. PMID 11404472 DOI: 10.1073/Pnas.131187998 |
0.398 |
|
| 2001 |
Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA, Lode HN. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. Journal of Immunology (Baltimore, Md. : 1950). 166: 6944-51. PMID 11359856 DOI: 10.4049/Jimmunol.166.11.6944 |
0.401 |
|
| 2001 |
Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 856s-864s. PMID 11300483 |
0.331 |
|
| 2001 |
Schrama D, thor Straten P, Fischer WH, McLellan AD, Bröcker EB, Reisfeld RA, Becker JC. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity. 14: 111-21. PMID 11239444 DOI: 10.1016/S1074-7613(01)00094-2 |
0.421 |
|
| 2000 |
Lode HN, Xiang R, Perri P, Pertl U, Lode A, Gillies SD, Reisfeld RA. What to do with targeted IL-2. Drugs of Today (Barcelona, Spain : 1998). 36: 321-36. PMID 12861355 DOI: 10.1358/Dot.2000.36.5.575044 |
0.368 |
|
| 2000 |
Yun CO, Nolan KF, Beecham EJ, Reisfeld RA, Junghans RP. Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors. Neoplasia (New York, N.Y.). 2: 449-59. PMID 11191112 DOI: 10.1038/Sj.Neo.7900108 |
0.441 |
|
| 2000 |
Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 4077-85. PMID 11118469 DOI: 10.1200/Jco.2000.18.24.4077 |
0.32 |
|
| 2000 |
Lode HN, Pertl U, Xiang R, Gaedicke G, Reisfeld RA. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma Medical and Pediatric Oncology. 35: 641-646. PMID 11107137 DOI: 10.1002/1096-911X(20001201)35:6<641::Aid-Mpo34>3.0.Co;2-R |
0.335 |
|
| 2000 |
Balicki D, Reisfeld RA, Pertl U, Beutler E, Lode HN. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 97: 11500-4. PMID 11016973 DOI: 10.1073/Pnas.210382997 |
0.357 |
|
| 2000 |
Lode HN, Xiang R, Gillies SD, Reisfeld RA. Amplification of T cell-mediated immune responses by antibody-cytokine fusion proteins Immunological Investigations. 29: 117-120. PMID 10854178 DOI: 10.3109/08820130009062293 |
0.388 |
|
| 2000 |
Lode HN, Reisfeld RA. Targeted cytokines for cancer immunotherapy. Immunologic Research. 21: 279-88. PMID 10852128 DOI: 10.1385/Ir:21:2-3:279 |
0.363 |
|
| 2000 |
Lode HN, Xiang R, Pertl U, Förster E, Schoenberger SP, Gillies SD, Reisfeld RA. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction. The Journal of Clinical Investigation. 105: 1623-30. PMID 10841521 DOI: 10.1172/Jci9177 |
0.349 |
|
| 2000 |
Xiang R, Lode HN, Chao TH, Ruehlmann JM, Dolman CS, Rodriguez F, Whitton JL, Overwijk WW, Restifo NP, Reisfeld RA. An autologous oral DNA vaccine protects against murine melanoma. Proceedings of the National Academy of Sciences of the United States of America. 97: 5492-7. PMID 10779556 DOI: 10.1073/Pnas.090097697 |
0.404 |
|
| 2000 |
Foon KA, Lutzky J, Baral RN, Yannelli JR, Hutchins L, Teitelbaum A, Kashala OL, Das R, Garrison J, Reisfeld RA, Bhattacharya-Chatterjee M. Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 376-84. PMID 10637253 DOI: 10.1200/Jco.2000.18.2.376 |
0.353 |
|
| 1999 |
Lode HN, Xiang R, Duncan SR, Theofilopoulos AN, Gillies SD, Reisfeld RA. Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12. Proceedings of the National Academy of Sciences of the United States of America. 96: 8591-6. PMID 10411920 DOI: 10.1073/Pnas.96.15.8591 |
0.393 |
|
| 1999 |
Lode HN, Moehler T, Xiang R, Jonczyk A, Gillies SD, Cheresh DA, Reisfeld RA. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proceedings of the National Academy of Sciences of the United States of America. 96: 1591-6. PMID 9990069 DOI: 10.1073/Pnas.96.4.1591 |
0.401 |
|
| 1999 |
Foon KA, Kashala O, Garrison J, Reisfeld RA, Teitelbaum A, Chatterjee M. P12 Immune responses in melanoma patients immunized with an anti-idiotype (Id) antibody mimicking GD2 Melanoma Research. 9: 327. DOI: 10.1097/00008390-199906000-00064 |
0.346 |
|
| 1999 |
Foon K, Lutzky J, Hutchins L, Teitelbaum A, Kashala O, Chakraborty M, Reisfeld R, Chatterjee M. Clinical and immune responses in metastatic melanoma patients immunized with an anti-idiotype (anti-Id) monoclonal antibody (mAb) mimicking disialoganglioside gd21 European Journal of Cancer. 35: S354. DOI: 10.1016/S0959-8049(99)81849-8 |
0.368 |
|
| 1998 |
REISFELD RA, HERTZ R. Purification of chorionic gonadotropin from the urine of patients with trophoblastic tumors. Biochimica Et Biophysica Acta. 43: 540-3. PMID 13740661 DOI: 10.1016/0006-3002(60)90477-7 |
0.304 |
|
| 1998 |
Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA. Immunocytokines: A promising approach to cancer immunotherapy Pharmacology and Therapeutics. 80: 277-292. PMID 9888698 DOI: 10.1016/S0163-7258(98)00033-3 |
0.426 |
|
| 1998 |
Straten PT, Guldberg P, Seremet T, Reisfeld RA, Zeuthen J, Becker JC. Activation of preexisting T cell clones by targeted interleukin 2 therapy. Proceedings of the National Academy of Sciences of the United States of America. 95: 8785-90. PMID 9671756 DOI: 10.1073/Pnas.95.15.8785 |
0.405 |
|
| 1998 |
Dreier T, Lode HN, Xiang R, Dolman CS, Reisfeld RA, Kang AS. Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities. Bioconjugate Chemistry. 9: 482-9. PMID 9667950 DOI: 10.1021/Bc980020E |
0.413 |
|
| 1998 |
Yu AL, Uttenreuther-Fischer MM, Huang CS, Tsui CC, Gillies SD, Reisfeld RA, Kung FH. Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2169-80. PMID 9626218 DOI: 10.1200/Jco.1998.16.6.2169 |
0.336 |
|
| 1998 |
Cirulli V, Crisa L, Beattie GM, Mally MI, Lopez AD, Fannon A, Ptasznik A, Inverardi L, Ricordi C, Deerinck T, Ellisman M, Reisfeld RA, Hayek A. KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. The Journal of Cell Biology. 140: 1519-34. PMID 9508783 DOI: 10.1083/Jcb.140.6.1519 |
0.359 |
|
| 1998 |
Lode HN, Dreier T, Xiang R, Varki NM, Kang AS, Reisfeld RA. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 95: 2475-80. PMID 9482910 DOI: 10.1073/Pnas.95.5.2475 |
0.405 |
|
| 1998 |
Lode HN, Xiang R, Dreier T, Varki NM, Gillies SD, Reisfeld RA. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood. 91: 1706-15. PMID 9473237 DOI: 10.1182/Blood.V91.5.1706.1706_1706_1715 |
0.391 |
|
| 1998 |
Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. Journal of Immunotherapy (Hagerstown, Md. : 1997). 21: 75-83. PMID 9456440 DOI: 10.1097/00002371-199801000-00010 |
0.421 |
|
| 1997 |
Reisfeld RA, Becker JC, Gillies SD. Immunocytokines: a new approach to immunotherapy of melanoma. Melanoma Research. 7: S99-106. PMID 9578424 DOI: 10.1097/00008390-199708001-00016 |
0.436 |
|
| 1997 |
Lode HN, Xiang R, Varki NM, Dolman CS, Gillies SD, Reisfeld RA. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. Journal of the National Cancer Institute. 89: 1586-94. PMID 9362156 DOI: 10.1093/Jnci/89.21.1586 |
0.35 |
|
| 1997 |
Xiang R, Lode HN, Dolman CS, Dreier T, Varki NM, Qian X, Lo KM, Lan Y, Super M, Gillies SD, Reisfeld RA. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy. Cancer Research. 57: 4948-55. PMID 9354462 |
0.323 |
|
| 1997 |
Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer. 80: 317-33. PMID 9217046 DOI: 10.1002/(Sici)1097-0142(19970715)80:2<317::Aid-Cncr21>3.0.Co;2-W |
0.392 |
|
| 1997 |
Hank J, Kendra K, Gan J, Ricci M, Surfus J, Shaker A, Reisfeld R, Gillies S, Sondel P. PRECLINICAL TESTING AND DEVELOPMENT OF CHIMERIC/HUMANIZED ANTI-GD2-INTERLEUKIN 2 FUSION PROTEIN Journal of Immunotherapy. 20: 416. DOI: 10.1097/00002371-199709000-00077 |
0.308 |
|
| 1997 |
Becker J, Bröcker E, Reisfeld R. In-situ cytokine therapy by immunokines: Induction of T-cell mediated antitumor immunity European Journal of Cancer. 33: S19. DOI: 10.1016/S0959-8049(97)89375-6 |
0.324 |
|
| 1997 |
Lode HN, Xiang R, Dreier T, Gillies S, Reisfeld R. Targeted cytokine delivery with recombinant antibody fusion proteins for therapeutic intervention European Journal of Cancer. 33: S70. DOI: 10.1016/S0959-8049(97)84693-X |
0.323 |
|
| 1996 |
Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA. Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy. The Journal of Clinical Investigation. 98: 2801-4. PMID 8981927 DOI: 10.1172/Jci119107 |
0.433 |
|
| 1996 |
Albertini MR, Gan J, Jaeger P, Hank JA, Storer B, Schell K, Rivest T, Surfus J, Reisfeld RA, Schiller JH, Sondel PM. Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 19: 278-95. PMID 8877722 DOI: 10.1097/00002371-199607000-00004 |
0.371 |
|
| 1996 |
Becker JC, Varki N, Bröcker EB, Reisfeld RA. Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma. The Journal of Investigative Dermatology. 107: 627-32. PMID 8823372 DOI: 10.1111/1523-1747.Ep12584237 |
0.374 |
|
| 1996 |
Reisfeld RA, Gillies SD. Recombinant antibody fusion proteins for cancer immunotherapy. Current Topics in Microbiology and Immunology. 213: 27-53. PMID 8815009 DOI: 10.1007/978-3-642-80071-9_3 |
0.464 |
|
| 1996 |
Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, Filardo EJ, Reisfeld RA. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proceedings of the National Academy of Sciences of the United States of America. 93: 9710-5. PMID 8790396 DOI: 10.1073/Pnas.93.18.9710 |
0.34 |
|
| 1996 |
Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA. An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proceedings of the National Academy of Sciences of the United States of America. 93: 7826-31. PMID 8755561 DOI: 10.1073/Pnas.93.15.7826 |
0.462 |
|
| 1996 |
Reisfeld RA, Gillies SD. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy. Journal of Clinical Laboratory Analysis. 10: 160-6. PMID 8731505 DOI: 10.1002/(Sici)1098-2825(1996)10:3<160::Aid-Jcla9>3.0.Co;2-F |
0.324 |
|
| 1996 |
Becker JC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA. T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. The Journal of Experimental Medicine. 183: 2361-6. PMID 8642346 DOI: 10.1084/Jem.183.5.2361 |
0.447 |
|
| 1996 |
Pancook JD, Becker JC, Gillies SD, Reisfeld RA. Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2. Cancer Immunology, Immunotherapy : Cii. 42: 88-92. PMID 8620525 DOI: 10.1007/S002620050256 |
0.391 |
|
| 1996 |
Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein. Cancer Research. 56: 1707-12. PMID 8620479 |
0.351 |
|
| 1996 |
Becker JC, Pancook JD, Gillies SD, Mendelsohn J, Reisfeld RA. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins. Proceedings of the National Academy of Sciences of the United States of America. 93: 2702-7. PMID 8610104 DOI: 10.1073/Pnas.93.7.2702 |
0.44 |
|
| 1996 |
Hank JA, Surfus JE, Gan J, Jaeger P, Gillies SD, Reisfeld RA, Sondel PM. ACTIVATION OF HUMAN EFFECTOR CELLS BY A TUMOR REACTIVE RECOMBINANT ANTI-GANGLIOSIDE GD2 INTERLEUKIN-2 FUSION PROTEIN Journal of Immunotherapy. 19: 463. DOI: 10.1097/00002371-199611000-00039 |
0.414 |
|
| 1995 |
Liu L, Barth RF, Adams DM, Soloway AH, Reisfeld RA. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. Journal of Hematotherapy. 4: 477-83. PMID 8581388 DOI: 10.1089/Scd.1.1995.4.477 |
0.362 |
|
| 1995 |
Becker JC, Brabletz T, Kirchner T, Conrad CT, Bröcker EB, Reisfeld RA. Negative transcriptional regulation in anergic T cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 2375-8. PMID 7892274 DOI: 10.1073/Pnas.92.6.2375 |
0.336 |
|
| 1995 |
Handgretinger R, Anderson K, Lang P, Dopfer R, Klingebiel T, Schrappe M, Reuland P, Gillies SD, Reisfeld RA, Niethammer D. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma European Journal of Cancer. 31: 261-267. PMID 7718335 DOI: 10.1016/0959-8049(94)00413-Y |
0.303 |
|
| 1995 |
Holzer U, Bethge W, Krull F, Ihle J, Handgretinger R, Reisfeld RA, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells Cancer Immunology Immunotherapy. 41: 129-136. PMID 7656271 DOI: 10.1007/Bf01527409 |
0.389 |
|
| 1995 |
Uttenreuther-Fischer MM, Huang CS, Reisfeld RA, Yu AL. Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients. Cancer Immunology, Immunotherapy : Cii. 41: 29-36. PMID 7641217 DOI: 10.1007/Bf01788957 |
0.314 |
|
| 1994 |
Hank JA, Surfus J, Gan J, Chew TL, Hong R, Tans K, Reisfeld R, Seeger RC, Reynolds CP, Bauer M. Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 15: 29-37. PMID 8110728 DOI: 10.1097/00002371-199401000-00004 |
0.315 |
|
| 1994 |
Sabzevari H, Gillies SD, Mueller BM, Pancook JD, Reisfeld RA. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice Proceedings of the National Academy of Sciences of the United States of America. 91: 9626-9630. PMID 7937818 DOI: 10.1073/Pnas.91.20.9626 |
0.424 |
|
| 1994 |
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79: 1157-64. PMID 7528107 DOI: 10.1016/0092-8674(94)90007-8 |
0.32 |
|
| 1994 |
Reisfeld RA, Mueller BM, Handgretinger R, Yu AL, Gillies SD. Chapter 15 Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotheraphy Progress in Brain Research. 101: 201-212. DOI: 10.1016/S0079-6123(08)61950-0 |
0.43 |
|
| 1993 |
Montgomery AM, Sabzevari H, Reisfeld RA. Production and regulation of gelatinase B by human T-cells. Biochimica Et Biophysica Acta. 1176: 265-8. PMID 8471628 DOI: 10.1016/0167-4889(93)90054-S |
0.302 |
|
| 1993 |
Barker E, Reisfeld RA. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells. Cancer Research. 53: 362-7. PMID 8417829 |
0.306 |
|
| 1993 |
Naramura M, Gillies SD, Mendelsohn J, Reisfeld RA, Mueller BM. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma Cancer Immunology Immunotherapy. 37: 343-349. PMID 8402738 DOI: 10.1007/Bf01518458 |
0.432 |
|
| 1993 |
Naramura M, Gillies SD, Mendelsohn J, Reisfeld RA, Mueller BM. Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cells Immunology Letters. 39: 91-99. PMID 8144194 DOI: 10.1016/0165-2478(93)90169-3 |
0.375 |
|
| 1993 |
Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells British Journal of Haematology. 83: 545-553. PMID 7686031 DOI: 10.1111/J.1365-2141.1993.Tb04689.X |
0.396 |
|
| 1992 |
Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2. Cancer Immunology, Immunotherapy : Cii. 34: 198-204. PMID 1756537 DOI: 10.1007/Bf01742313 |
0.365 |
|
| 1992 |
Gillies SD, Reilly EB, Lo KM, Reisfeld RA. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 89: 1428-32. PMID 1741398 DOI: 10.1073/Pnas.89.4.1428 |
0.44 |
|
| 1992 |
Haenseler E, Esswein A, Vitols KS, Montejano Y, Mueller BM, Reisfeld RA, Huennekens FM. Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugate. Biochemistry. 31: 891-7. PMID 1731945 DOI: 10.1021/Bi00118A035 |
0.403 |
|
| 1992 |
Handgretinger R, Baader P, Dopfer R, Klingebiel T, Reuland P, Treuner J, Reisfeld RA, Niethammer D. A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a. Cancer Immunology, Immunotherapy : Cii. 35: 199-204. PMID 1638557 DOI: 10.1007/Bf01756188 |
0.346 |
|
| 1992 |
Reisfeld RA. Monoclonal antibodies in cancer immunotherapy. Clinics in Laboratory Medicine. 12: 201-16. PMID 1611818 DOI: 10.1016/S0272-2712(18)30513-4 |
0.386 |
|
| 1992 |
Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis Proceedings of the National Academy of Sciences of the United States of America. 89: 11832-11836. PMID 1465406 DOI: 10.1073/Pnas.89.24.11832 |
0.429 |
|
| 1992 |
Reisfeld RA. Potential of genetically engineered monoclonal antibodies for cancer immunotherapy. Pigment Cell Research. 109-12. PMID 1409412 DOI: 10.1111/J.1600-0749.1990.Tb00359.X |
0.317 |
|
| 1992 |
Saleh MN, Khazaeli M, Wheeler RH, Allen L, Tilden AB, Grizzle W, Reisfeld RA, Yu AL, Gillies SD, LoBuglio AF. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma Human Antibodies. 3: 19-24. DOI: 10.3233/Hab-1992-3104 |
0.347 |
|
| 1992 |
Hank JA, Surfus J, Gan J, Hong R, Tans K, Reisfeld R, Ettinger L, Senger R, Reynolds P, Friedrich S, Bauer M, Wiersma S, Hammond D, Sondel PM. COMBINED IMMUNOLOGIC THERAPY WITH INTERLEUKIN-2 AND ANTI-GD-2 MONOCLONAL ANTIBODY 14.G2a INDUCES IN VIVO IMMUNOLOGIC CONDITIONS ABLE TO MEDIATE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN VITRO, IN PEDIATRIC NEUROBLASTOMA PATIENTS Journal of Immunotherapy. 11: 126. DOI: 10.1097/00002371-199202000-00022 |
0.379 |
|
| 1991 |
Reuland P, Handgretinger R, Smykowsky H, Dopfer R, Klingebiel T, Miller BM, Reisfeld RA, Gallagher S, Koscelniak E, Treuner J. Application of the murine anti-Gd-2 antibody 14.Gd-2a for diagnosis and therapy of neuroblastoma. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 18: 121-5. PMID 2010296 DOI: 10.1016/0883-2897(91)90058-S |
0.319 |
|
| 1991 |
Mueller BM, Romerdahl CA, Trent JM, Reisfeld RA. Suppression of Spontaneous Melanoma Metastasis in Seid Mice with an Antibody to the Epidermal Growth Factor Receptor Cancer Research. 51: 2193-2198. PMID 2009538 |
0.325 |
|
| 1991 |
Gillies SD, Young D, Lo KM, Foley SF, Reisfeld RA. Expression of genetically engineered immunoconjugates of lymphotoxin and a chimeric anti-ganglioside GD2 antibody Hybridoma. 10: 347-356. PMID 1916847 DOI: 10.1089/Hyb.1991.10.347 |
0.436 |
|
| 1991 |
Dorai H, Mueller BM, Reisfeld RA, Gillies SD. Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function Hybridoma. 10: 211-217. PMID 1874515 DOI: 10.1089/Hyb.1991.10.211 |
0.348 |
|
| 1991 |
Mueller BM, Reisfeld RA. Potential of the scid mouse as a host for human tumors Cancer and Metastasis Review. 10: 193-200. PMID 1764764 DOI: 10.1007/Bf00050791 |
0.359 |
|
| 1991 |
Jung G, Freimann U, Von Marschall Z, Reisfeld RA, Wilmanns W. Target cell-induced T cell activation with bi- and trispecific antibody fragments. European Journal of Immunology. 21: 2431-5. PMID 1655465 DOI: 10.1002/Eji.1830211020 |
0.397 |
|
| 1991 |
Möller SA, Reisfeld RA. Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes. Cancer Immunology, Immunotherapy : Cii. 33: 210-6. PMID 1647871 DOI: 10.1007/Bf01744939 |
0.454 |
|
| 1990 |
Harel W, Shau H, Hadley CG, Morgan AC, Reisfeld RA, Cheresh DA, Mitchell MS. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. Cancer Research. 50: 6311-5. PMID 2400994 |
0.335 |
|
| 1990 |
Hank JA, Robinson RR, Surfus J, Mueller BM, Reisfeld RA, Cheung NK, Sondel PM. Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer Research. 50: 5234-9. PMID 2386933 |
0.372 |
|
| 1990 |
Mueller BM, Reisfeld RA, Gillies SD. Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2 Proceedings of the National Academy of Sciences of the United States of America. 87: 5702-5705. PMID 2198570 DOI: 10.1073/Pnas.87.15.5702 |
0.359 |
|
| 1990 |
Mueller BM, Wrasidlo WA, Reisfeld RA. Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers Bioconjugate Chemistry. 1: 325-330. PMID 1711377 DOI: 10.1021/Bc00005A005 |
0.387 |
|
| 1989 |
Bruchelt G, Handgretinger R, Kimmig A, Goeke B, Siedner R, Reisfeld RA, Niethammer D, Treuner J. Effects of granulocytes on human neuroblastoma cells measured by chemiluminescence and chromium-51 release assay. Journal of Bioluminescence and Chemiluminescence. 3: 93-6. PMID 2728918 DOI: 10.1002/Bio.1170030212 |
0.352 |
|
| 1989 |
Wargalla UC, Reisfeld RA. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 5146-50. PMID 2544891 DOI: 10.1073/Pnas.86.13.5146 |
0.358 |
|
| 1989 |
Bruchelt G, Handgretinger R, Fierlbeck G, Kimmig A, Dopfer R, Reisfeld RA, Treuner J, Niethammer D. Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors. Immunology Letters. 22: 217-20. PMID 2509332 DOI: 10.1016/0165-2478(89)90194-6 |
0.339 |
|
| 1988 |
Yang HM, Reisfeld RA. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proceedings of the National Academy of Sciences of the United States of America. 85: 1189-93. PMID 3422487 DOI: 10.1073/Pnas.85.4.1189 |
0.411 |
|
| 1988 |
Yang HM, Reisfeld RA. Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal antibody 9.2.27 conjugate directed to a human melanoma proteoglycan. Journal of the National Cancer Institute. 80: 1154-9. PMID 3261803 DOI: 10.1093/Jnci/80.14.1154 |
0.41 |
|
| 1988 |
Mueller BM, Wrasidlo WA, Reisfeld RA. Determination of the number of ε-amino groups available for conjugation of effector molecules to monoclonal antibodies Hybridoma. 7: 453-456. PMID 3143663 DOI: 10.1089/Hyb.1988.7.453 |
0.4 |
|
| 1987 |
Reisfeld RA, Cheresh DA. Human tumor antigens. Advances in Immunology. 40: 323-77. PMID 3591561 DOI: 10.1016/S0065-2776(08)60242-4 |
0.461 |
|
| 1987 |
Mujoo K, Cheresh DA, Yang HM, Reisfeld RA. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Research. 47: 1098-104. PMID 3100030 |
0.384 |
|
| 1987 |
Cheresh DA, Pytela R, Pierschbacher MD, Klier FG, Ruoslahti E, Reisfeld RA. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. The Journal of Cell Biology. 105: 1163-73. PMID 2443507 DOI: 10.1083/Jcb.105.3.1163 |
0.349 |
|
| 1986 |
Honsik CJ, Jung G, Reisfeld RA. Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin. Proceedings of the National Academy of Sciences of the United States of America. 83: 7893-7. PMID 3094017 DOI: 10.1073/Pnas.83.20.7893 |
0.479 |
|
| 1986 |
Jung G, Honsik CJ, Reisfeld RA, Müller-Eberhard HJ. Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates. Proceedings of the National Academy of Sciences of the United States of America. 83: 4479-83. PMID 3086885 DOI: 10.1073/Pnas.83.12.4479 |
0.405 |
|
| 1986 |
Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Research. 46: 5112-8. PMID 3019521 |
0.33 |
|
| 1986 |
Noronha AB, Harper JR, Ilyas AA, Reisfeld RA, Quarles RH. Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells. Journal of Neurochemistry. 47: 1558-65. PMID 2428939 DOI: 10.1111/J.1471-4159.1986.Tb00795.X |
0.422 |
|
| 1985 |
Schulz G, Staffileno LK, Reisfeld RA, Dennert G. Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells Journal of Experimental Medicine. 161: 1315-1325. PMID 4009116 DOI: 10.1084/Jem.161.6.1315 |
0.458 |
|
| 1985 |
Walker LE, Ketler TA, Houghten RA, Schulz G, Chersi A, Reisfeld RA. Human major histocompatibility complex class I antigens: Residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site Proceedings of the National Academy of Sciences of the United States of America. 82: 539-542. PMID 3881768 DOI: 10.1073/Pnas.82.2.539 |
0.354 |
|
| 1985 |
Cheresh DA, Honsik CJ, Staffileno LK, Jung G, Reisfeld RA. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proceedings of the National Academy of Sciences of the United States of America. 82: 5155-9. PMID 3860849 DOI: 10.1073/Pnas.82.15.5155 |
0.471 |
|
| 1984 |
Bumol TF, Harper JR, Chee DO, Reisfeld RA. Antigenic expression of human melanoma cells in serum-free medium. Advances in Experimental Medicine and Biology. 172: 455-70. PMID 6731148 DOI: 10.1007/978-1-4615-9376-8_26 |
0.437 |
|
| 1984 |
Cheresh DA, Harper JR, Schulz G, Reisfeld RA. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proceedings of the National Academy of Sciences of the United States of America. 81: 5767-71. PMID 6385004 DOI: 10.1073/Pnas.81.18.5767 |
0.411 |
|
| 1984 |
Bumol TF, Chee DO, Reisfeld RA. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen. Hybridoma. 1: 283-92. PMID 6208129 DOI: 10.1089/Hyb.1.1982.1.283 |
0.412 |
|
| 1984 |
Cheresh DA, Reisfeld RA, Varki AP. O-Acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant Science. 225: 844-846. PMID 6206564 DOI: 10.1126/Science.6206564 |
0.375 |
|
| 1983 |
Schulz G, Bumol TF, Reisfeld RA. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 80: 5407-11. PMID 6577434 DOI: 10.1073/Pnas.80.17.5407 |
0.468 |
|
| 1983 |
Bumol TF, Wang QC, Reisfeld RA, Kaplan NO. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 80: 529-33. PMID 6572905 DOI: 10.1073/Pnas.80.2.529 |
0.471 |
|
| 1983 |
Church WR, Walker LE, Houghten RA, Reisfeld RA. Anti-HLA antibodies of predetermined specificity: A chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain Proceedings of the National Academy of Sciences of the United States of America. 80: 255-258. PMID 6571999 DOI: 10.1073/Pnas.80.1.255 |
0.363 |
|
| 1983 |
Bumol TF, Reisfeld RA. Biosynthesis and secretion of fibronectin in human melanoma cells. Journal of Cellular Biochemistry. 21: 129-40. PMID 6411743 DOI: 10.1002/Jcb.240210204 |
0.371 |
|
| 1983 |
Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM, Lerner RA. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proceedings of the National Academy of Sciences of the United States of America. 80: 4949-53. PMID 6192445 DOI: 10.1073/Pnas.80.16.4949 |
0.32 |
|
| 1983 |
Harper JR, Reisfeld RA. Inhibition of Anchorage-Independent Growth of Human Melanoma Cells by a Monoclonal Antibody to a Chondroitin Sulfate Proteoglycan Journal of the National Cancer Institute. 71: 225-225. DOI: 10.1093/Jnci/71.2.259 |
0.457 |
|
| 1982 |
Reisfeld RA. Monoclonal antibodies to human malignant melanoma. Nature. 298: 325-6. PMID 7088181 DOI: 10.1038/298325A0 |
0.388 |
|
| 1982 |
Harper JR, Bumol TF, Reisfeld RA. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens. Hybridoma. 1: 423-32. PMID 6208137 DOI: 10.1089/Hyb.1.1982.1.423 |
0.444 |
|
| 1982 |
Quaranta V, Zanetti M, Reisfeld RA. A recurrent idiotype on monoclonal anti-human Ia antibodies Journal of Experimental Medicine. 156: 1551-1556. PMID 6182263 DOI: 10.1084/Jem.156.5.1551 |
0.432 |
|
| 1982 |
Church WR, Poulik MD, Reisfeld RA. Association of human and bovine beta 2-microglobulins with detergent solubilized HLA-A,B antigens. Journal of Immunological Methods. 52: 97-104. PMID 6181168 DOI: 10.1016/0022-1759(82)90354-4 |
0.307 |
|
| 1982 |
Bumol TF, Reisfeld RA. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 1245-9. PMID 6175965 DOI: 10.1073/Pnas.79.4.1245 |
0.436 |
|
| 1982 |
Walker LE, Reisfeld RA. Human histocompatibility antigens: Isolation and chemical characterization Journal of Immunological Methods. 49. PMID 6175704 DOI: 10.1016/0022-1759(82)90123-5 |
0.35 |
|
| 1981 |
Eskinazi DP, Molinaro GA, Reisfeld RA, Ferrone S. Cellular and molecular heterogeneity of H-2Kk antigens. Journal of Immunogenetics. 8: 101-6. PMID 7229421 DOI: 10.1111/J.1744-313X.1981.Tb00747.X |
0.402 |
|
| 1981 |
Morgan AC, Galloway DR, Jensen FC, Giovanella BC, Reisfeld RA. Immunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytes Proceedings of the National Academy of Sciences of the United States of America. 78: 3834-3838. PMID 6267607 DOI: 10.1073/Pnas.78.6.3834 |
0.36 |
|
| 1981 |
Morgan AC, Galloway DR, Reisfeld RA. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein Hybridoma. 1: 27-36. PMID 6208119 DOI: 10.1089/Hyb.1.1981.1.27 |
0.468 |
|
| 1980 |
Morgan AC, Galloway DR, Wilson BS, Reisfeld RA. Human melanoma associated antigens: A solid-phase assay for detection of specific antibody Journal of Immunological Methods. 39: 233-246. PMID 7462650 DOI: 10.1016/0022-1759(80)90058-7 |
0.42 |
|
| 1980 |
Walker LE, Ferrone S, Pellegrino MA, Reisfeld RA. Structural polymorphism of the β chain of human HLA-DR antigens Molecular Immunology. 17: 1443-1448. PMID 6975425 DOI: 10.1016/0161-5890(80)90169-8 |
0.304 |
|
| 1980 |
McCabe RP, Indiveri F, Galloway DR, Ferrone S, Reisfeld RA. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: Serologic and immunochemical evidence Journal of the National Cancer Institute. 65: 703-707. PMID 6158590 DOI: 10.1093/Jnci/65.4.703 |
0.354 |
|
| 1980 |
Eskinazi D, Molinaro G, Reisfeld R, Ferrone S. Indirect rosette microassay: comparison of protein a with purified anti-Ig antibody Immunology Letters. 1: 259-263. DOI: 10.1016/0165-2478(80)90004-8 |
0.377 |
|
| 1979 |
Callahan GN, Allison JP, Pellegrino MA, Reisfeld RA. Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells. Journal of Immunology (Baltimore, Md. : 1950). 122: 70-4. PMID 762424 |
0.516 |
|
| 1979 |
Silver J, Walker LE, Reisfeld RA, Pellegrino MA, Ferrone S. Structural studies of murine I-E and human DR antigens Molecular Immunology. 16: 37-42. PMID 447368 DOI: 10.1016/0161-5890(79)90025-7 |
0.347 |
|
| 1979 |
Natali PG, Pellegrino MA, Walker L, Ferrone S, Reisfeld RA. Antibody-coated protein A-bearing Staphylococcus aureus: a versatile and stable immune reagent. Journal of Immunological Methods. 25: 255-64. PMID 368250 DOI: 10.1016/0022-1759(79)90113-3 |
0.4 |
|
| 1979 |
McCabe RP, Quaranta V, Frugis L, Ferrone S, Reisfeld RA. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens Journal of the National Cancer Institute. 62: 455-463. PMID 283276 DOI: 10.1093/Jnci/62.3.455 |
0.422 |
|
| 1979 |
Walker LE, Allison JP, Silver J, Pellegrino MA, Reisfeld RA, Ferrone S. IS SEROLOGICAL POLYMORPHISM OF HUMAN DR ANTIGENS DETERMINED BY STRUCTURAL DIFFERENCES IN THE SMALLER (β) CHAIN Cell Biology and Immunology of Leukocyte Function. 271-276. DOI: 10.1016/B978-0-12-569650-0.50041-3 |
0.557 |
|
| 1978 |
Allison JP, Belvedere M, Reisfeld RA, Pellegrino MA, Ferrone S. Serologic and immunochemical characterization of HLA-A9 xenoantisera. Journal of Immunology (Baltimore, Md. : 1950). 121: 579-85. PMID 681750 |
0.436 |
|
| 1978 |
David GS, Reisfeld RA, Chino TH. Continuous production of carcinoembryonic antigen in hollow fiber cell culture units: brief communication. Journal of the National Cancer Institute. 60: 303-6. PMID 621750 DOI: 10.1093/Jnci/60.2.303 |
0.317 |
|
| 1978 |
Allison JP, Ferrone S, Walker LE, Pellegrino MA, Silver J, Reisfeld RA. Partial amino acid sequence of HLA‐A9 antigen purified with a specific xenoantiserum Transplantation. 26: 451-453. PMID 569916 |
0.41 |
|
| 1978 |
Allison JP, Walker LE, Russell WA, Pellegrino MA, Ferrone S, Reisfeld RA, Frelinger JA, Silver J. Murine Ia and human DR antigens. Homology of amino-terminal sequences Proceedings of the National Academy of Sciences of the United States of America. 75: 3953-3956. PMID 99745 DOI: 10.1073/Pnas.75.8.3953 |
0.517 |
|
| 1978 |
McCabe RP, Ferrone S, Pellegrino MA, Kern DH, Holmes EC, Reisfeld RA. Purification and immunologic evaluation of human melnoma-associated antigens. Journal of the National Cancer Institute. 60: 773-7. PMID 75978 DOI: 10.1093/Jnci/60.4.773 |
0.419 |
|
| 1977 |
Wang R, Sevier ED, Reisfeld RA, David GS. Semi-automatic solid-phase radioimmunoassay for carcinoembryonic antigen. Journal of Immunological Methods. 18: 157-64. PMID 915307 DOI: 10.1016/0022-1759(77)90167-3 |
0.361 |
|
| 1977 |
Allison JP, Ferrone S, Pellegrino MA, Reisfeld RA. Procedure for the selection of HLA xenoantisera for immunochemical characterization of HLA antigens. Transplantation Proceedings. 9: 601-4. PMID 194373 |
0.421 |
|
| 1977 |
Allison JP, Pellegrino MA, Ferrone S, Callahan GN, Reisfeld RA. Biologic and chemical characterization of HLA antigens in human serum. Journal of Immunology (Baltimore, Md. : 1950). 118: 1004-9. PMID 191523 |
0.456 |
|
| 1977 |
Allison JP, Pellegrino MA, Reisfeld RA, Ferrone S. An immune adsorption technique for analysis of antigenic determinants reacting with HLA antisera. Transplantation Proceedings. 9: 1691-3. PMID 74875 |
0.434 |
|
| 1977 |
Pellegrino MA, Ferrone S, Reisfeld RA, Irie RF, Golub SH. Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma. Cancer. 40: 36-41. PMID 69483 DOI: 10.1002/1097-0142(197707)40:1<36::Aid-Cncr2820400108>3.0.Co;2-7 |
0.429 |
|
| 1977 |
Ferrone S, Mittal KK, Pellegrino MA, Allison JP, Reisfeld RA. Immunogenicity of HLA antigens purified from serum. Transplantation. 23: 7-15. PMID 65035 DOI: 10.1097/00007890-197701000-00002 |
0.532 |
|
| 1976 |
Roth JA, Holmes EC, Reisfeld RA, Slocum HK, Morton DL. Isolation of a soluble tumor-associated antigen from human melanoma. Cancer. 37: 104-10. PMID 1247946 DOI: 10.1002/1097-0142(197601)37:1<104::Aid-Cncr2820370115>3.0.Co;2-I |
0.429 |
|
| 1976 |
Ferrone S, Mickey MR, Terasaki PI, Reisfeld RA, Pellegrino MA. Humoral sensitization in parous women: cytotoxic antibodies to non HL-A antigens. Transplantation. 22: 61-8. PMID 936285 |
0.363 |
|
| 1976 |
Ferrone S, Pellegrino MA, Allison JP, Reisfeld RA. [Biological and chemical aspects of histocompatibility antigens in serum]. Haematologica. 61: 397-417. PMID 828605 |
0.455 |
|
| 1976 |
Pellegrino MA, Ferrone S, Reisfeld RA. Receptors for complement components and xenogeneic erythrocytes on human T- and B-lymphoid cells La Ricerca in Clinica E in Laboratorio. 6: 99-110. PMID 798257 DOI: 10.1007/Bf02949080 |
0.327 |
|
| 1976 |
Ferrone S, Pellegrino MA, Reisfeld RA. The major histocompatibility complex in man: biological and molecular approaches Progress in Allergy. 114-177. PMID 63954 DOI: 10.1159/000399399 |
0.393 |
|
| 1976 |
Reisfeld RA, Allison JP, Ferrone S, Pellegrino MA, Poulik MD. HL-A antigens in serum and urine: isolation, characterization, and immunogenic properties. Transplantation Proceedings. 8: 173-8. PMID 59439 |
0.444 |
|
| 1976 |
Sevier ED, Reisfeld RA. Semi-automatic solid-phase double-antibody radioimmunoassay for beta2-microglobulin. Immunochemistry. 13: 35-7. PMID 56306 DOI: 10.1016/0019-2791(76)90294-9 |
0.335 |
|
| 1975 |
David GS, Reisfeld RA. Binding of carcinoembryonic antigen (CEA) to concanavalin A-sepharose: storage of high-specific-activity 125I-CEA. Journal of the National Cancer Institute. 53: 1005-10. PMID 4473556 DOI: 10.1093/Jnci/53.4.1005 |
0.33 |
|
| 1975 |
Ferrone S, Pellegrino MA, Billing R, Terasaki PI, Reisfeld RA. Production of anti-W24 xenoantisera in rabbits. Tissue Antigens. 5: 41-7. PMID 1138440 DOI: 10.1111/J.1399-0039.1975.Tb00525.X |
0.445 |
|
| 1975 |
Ferrone S, Ting A, Pellegrino MA, Terasaki PI, Reisfeld RA. Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants. The Journal of Clinical Investigation. 55: 388-94. PMID 1092715 DOI: 10.1172/Jci107942 |
0.391 |
|
| 1975 |
Oh SK, Pellegrino MA, Ferrone S, Sevier ED, Reisfeld RA. Soluble HL-A antigens in serum. I. Isolation and purification. European Journal of Immunology. 5: 161-6. PMID 789087 DOI: 10.1002/Eji.1830050302 |
0.396 |
|
| 1975 |
Pellegrino MA, Ferrone S, Dierich MP, Reisfeld RA. Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide. Clinical Immunology and Immunopathology. 3: 324-33. PMID 233982 DOI: 10.1016/0090-1229(75)90019-7 |
0.308 |
|
| 1975 |
Callahan GN, Ferrone S, Allison JP, Reisfeld RA. Detection of H-2 antigens in serum. Transplantation. 20: 431-3. PMID 174256 DOI: 10.1097/00007890-197511000-00014 |
0.485 |
|
| 1975 |
Pellegrino MA, Ferrone S, Dierich MP, Pellegrino A, Reisfeld RA. Inhibitory effect of normal mammalian sera on the rosette formation of human lymphocytes with sheep red blood cells. Clinical Immunology and Immunopathology. 4: 85-95. PMID 123840 DOI: 10.1016/0090-1229(75)90042-2 |
0.402 |
|
| 1975 |
Reisfeld RA, Pellegrino MA, Dierich MP, Ferrone S. Cultured human lymphoid cells: tools for the biological and molecular characterization of antigens and their recognition systems. In Vitro. 11: 173-85. PMID 51826 DOI: 10.1007/Bf02616333 |
0.369 |
|
| 1975 |
Reisfeld RA, Sevier ED, Pellegrino MA, Ferrone S, Poulik MD. Association of HL-A antigens andβ 2-microglobulin at the cellular and molecular level Immunogenetics. 2: 183-197. DOI: 10.1007/Bf01572286 |
0.423 |
|
| 1974 |
Pellegrino MA, Ferrone S, Pellegrino AG, Oh SK, Reisfeld RA. Evaluation of two sources of soluble HL-A antigens: platelets and serum. European Journal of Immunology. 4: 250-5. PMID 4851933 DOI: 10.1002/Eji.1830040405 |
0.35 |
|
| 1974 |
Ferrone S, Pellegrino MA, Dierich MP, Reisfeld RA. Effect of inhibitors of macromolecular synthesis on HL-A antibody mediated lysis of cultured lymphoblasts. Tissue Antigens. 4: 275-82. PMID 4528542 DOI: 10.1111/J.1399-0039.1974.Tb00253.X |
0.4 |
|
| 1974 |
Pellegrino MA, Ferrone S, Cooper NR, Dierich MP, Reisfeld RA. Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding. The Journal of Experimental Medicine. 140: 578-90. PMID 4527075 DOI: 10.1084/Jem.140.2.578 |
0.422 |
|
| 1974 |
Oh SK, Pellegrino MA, Reisfeld RA. Hypertonic salt extraction of HL-A antigens: assessment of protease activity. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 145: 1272-7. PMID 4208043 DOI: 10.3181/00379727-145-37995 |
0.421 |
|
| 1974 |
Ferrone S, Pellegrino MA, Dierich MP, Reisfeld RA. Expression of histocompatibility antigens during the growth cycle of cultured lymphoid cells. Current Topics in Microbiology and Immunology. 66: 1-27. PMID 4140052 DOI: 10.1007/978-3-642-65908-9_1 |
0.334 |
|
| 1974 |
Pellegrino MA, Ferrone S, Mittal KK, Götze D, Terasaki PI, Reisfeld RA. Cross-reactivity between human and murine lymphocyte antigens: III. Reactivity of H-2 allo- and xenoantisera with human lymphoid cells Immunogenetics. 1: 158-173. DOI: 10.1007/Bf01564056 |
0.417 |
|
| 1973 |
Mittal KK, Ferrone S, Mickey MR, Pellegrino MA, Reisfeld RA, Terasaki PI. Serological characterization of natural antihuman lymphocytotoxic antibodies in mammalian sera. Transplantation. 16: 287-94. PMID 4745116 DOI: 10.1097/00007890-197310000-00003 |
0.409 |
|
| 1973 |
Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture. The Journal of Experimental Medicine. 137: 55-68. PMID 4734592 DOI: 10.1084/Jem.137.1.55 |
0.401 |
|
| 1973 |
Brautbar C, Pellegrino MA, Ferrone S, Reisfeld RA, Payne R, Hayflick L. Fate of HL-A antigens in aging cultured human diploid cell strains. II. Quantitative absorption studies. Experimental Cell Research. 78: 367-75. PMID 4698170 DOI: 10.1016/0014-4827(73)90081-5 |
0.338 |
|
| 1973 |
Götze D, Reisfeld RA, Klein J. Antibody against Ir-region controlled antigen in mice. Die Naturwissenschaften. 60: 355-6. PMID 4542703 DOI: 10.1007/Bf00599912 |
0.355 |
|
| 1973 |
Mittal KK, Ferrone S, Mickey MR, Pellegrino MA, Reisfeld RA, Terasaki PI. Specificity of lymphocytotoxic anti-human antibodies in normal rabbit sera. Tissue Antigens. 3: 88-94. PMID 4203769 DOI: 10.1111/J.1399-0039.1973.Tb00982.X |
0.396 |
|
| 1973 |
Ferrone S, Cooper NR, Pellegrino MA, Reisfeld RA. Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera. Proceedings of the National Academy of Sciences of the United States of America. 70: 3665-8. PMID 4128546 DOI: 10.1073/Pnas.70.12.3665 |
0.389 |
|
| 1973 |
Pellegrino MA, Ferrone S, Pellegrino A, Reisfeld RA. The expression of HL-A antigens during the growth cycle of cultured human lymphoid cells. Clinical Immunology and Immunopathology. 1: 182-9. PMID 4128502 DOI: 10.1016/0090-1229(73)90018-4 |
0.389 |
|
| 1972 |
Ferrone S, Del Villano BC, Pellegrino MA, Lerner RA, Reisfeld RA. Expression of HL-A antigens on the surface of cultured human lymphoid cells: effect of inhibitors of protein and nucleic acid synthesis. Tissue Antigens. 2: 447-53. PMID 4648386 DOI: 10.1111/J.1399-0039.1972.Tb00065.X |
0.372 |
|
| 1972 |
Reisfeld RA, Kahan BD. Extraction and purification of soluble histocompatibility antigens. Transplantation Reviews. 6: 81-112. PMID 4108878 DOI: 10.1111/J.1600-065X.1971.Tb00460.X |
0.321 |
|
| 1971 |
Reisfeld RA, Pellegrino MA, Kahan BD. Salt extraction of soluble HL-A antigens. Science (New York, N.Y.). 172: 1134-6. PMID 5574518 DOI: 10.1126/Science.172.3988.1134 |
0.351 |
|
| 1969 |
Kahan BD, Reisfeld RA. Immunogenicity of electrophoretically purified guinea pig transplantation antigen. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 130: 765-9. PMID 4886525 DOI: 10.3181/00379727-130-33651 |
0.325 |
|
| 1969 |
Paul WE, Benacerraf B, Siskind GW, Goidl DA, Reisfeld RA. The anamnestic antibody response to type 3 specific pneumococcal polysaccharide. The Journal of Experimental Medicine. 130: 77-89. PMID 4389341 DOI: 10.1084/Jem.130.1.77 |
0.362 |
|
| 1969 |
Sanders JH, Fahey JL, Finegold I, Ein D, Reisfeld R, Berard C. Multiple anomalous immunoglobulins: Clinical, structural and cellular studies in three patients The American Journal of Medicine. 47: 43-59. PMID 4183355 DOI: 10.1016/0002-9343(69)90240-X |
0.352 |
|
| 1968 |
Koshland ME, Reisfeld RA, Dray S. Differences in amino acid composition related to allotypic and antibody specificity of rabbit IgG heavy chains Immunochemistry. 5: 471-483. DOI: 10.1016/0019-2791(68)90183-3 |
0.301 |
|
| 1966 |
Reisfeld RA, Hyslop NE. Separation of 7S gamma-1-globulin, 7S gamma-2-globulin and macroglobulin guinea pig antibodies. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 121: 508-14. PMID 5933972 DOI: 10.3181/00379727-121-30817 |
0.364 |
|
| 1966 |
Reisfeld RA, Small PA. Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science (New York, N.Y.). 152: 1253-5. PMID 4160819 DOI: 10.1126/Science.152.3726.1253 |
0.351 |
|
| Show low-probability matches. |
